Welcome to our dedicated page for PROSPECT CAPITAL SEC filings (Ticker: PSEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PROSPECT CAPITAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PROSPECT CAPITAL's regulatory disclosures and financial reporting.
Prospect Capital Corporation filed a preliminary pricing supplement for new Prospect Capital InterNotes, offering fixed-rate senior unsecured notes in three tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032, each sold at 100.000% of principal. The notes pay interest semi-annually on May 15 and November 15, starting May 15, 2026, with record dates on May 1 and November 1. Each series is callable at 100.000% beginning May 15, 2026, and includes a Survivor’s Option.
The trade date is November 3, 2025 with settlement on November 6, 2025. Minimum denominations are $1,000 and integral multiples thereof, DTC book-entry only. Notes will be sold through InspereX as Purchasing Agent, with agent concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). In recent activity, the company repurchased $20.3 million aggregate principal of its 3.437% 2028 Notes at prices of 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation priced three new Prospect Capital InterNotes under its shelf, issuing fixed‑rate senior unsecured notes due 2028, 2030 and 2032. The tranches are: 6.250% Notes due 2028 with $415,000 principal, 6.500% Notes due 2030 with $74,000, and 6.750% Notes due 2032 with $52,000, each sold at 100.000% of principal.
Net proceeds are $410,331.25 (2028), $72,742.00 (2030) and $50,986.00 (2032) after selling concessions. Interest is paid semi‑annually on April 15 and October 15, beginning April 15, 2026. Each series includes a Survivor’s Option and is callable at 100.000% on April 15, 2026 and every business day thereafter, plus accrued interest.
The notes settle on October 30, 2025 in DTC book‑entry form and are issued under the existing 2012 Indenture, as further supplemented. Recent activity includes the repurchase of $20.3 million aggregate principal of the 3.437% 2028 Notes at 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation filed Post-Effective Amendment No. 117 to its Form N-2 registration statement (Reg. No. 333-269714). The filing, made under Rule 462(d), is solely to add exhibits and becomes effective immediately upon filing. It does not modify any other part of the registration statement.
The registration statement contemplates offerings “from time to time after the effective date.” This amendment consists of a facing page, an explanatory note, and Part C listing the exhibits, which are incorporated by reference.
Prospect Capital Corporation launched a primary offering of Prospect Capital InterNotes under its shelf, with three fixed-rate tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032. Each note pays interest semi-annually on April 15 and October 15, starting April 15, 2026, and is callable at 100% beginning April 15, 2026 and on any business day thereafter.
The notes will be sold at 100.000% of principal, with selling concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). Minimum denomination is $1,000, DTC book-entry only. A Survivor’s Option applies as stated, allowing repayment at 100% of principal plus accrued interest, subject to annual aggregate and per-decedent limits.
Key dates include a trade date of October 27, 2025 and settlement on October 30, 2025. Recent activity noted a repurchase of $20.3 million aggregate principal of the 3.437% 2028 notes at prices between 88.95% and 89.95%, plus accrued interest.
Prospect Capital Corporation priced three Prospect Capital InterNotes under its 424(b)(2) program: 6.250% Notes due 2028 ($189,000 principal), 6.500% Notes due 2030 ($135,000), and 6.750% Notes due 2032 ($55,000). Each series priced at 100% of principal with semi-annual interest and first coupons on April 15, 2026.
The 2028 Notes carry a 1.125% gross concession with net proceeds of $186,873.75; the 2030 Notes carry a 1.700% gross concession with net proceeds of $132,705.00; the 2032 Notes carry a 1.950% gross concession with net proceeds of $53,927.50. All are unsecured senior obligations with a Survivor’s Option and are callable at 100% on April 15, 2026 and thereafter, plus accrued interest.
Trade date was October 20, 2025, with settlement on October 23, 2025, $1,000 minimum denomination, DTC book-entry. Recent activity disclosed a repurchase of $20.3 million aggregate principal of 3.437% 2028 Notes at 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation filed Post-Effective Amendment No. 116 to its Form N-2 registration statement (Registration No. 333-269714). The filing was made under Rule 462(d) solely to add exhibits and became effective immediately upon filing.
The amendment consists of a facing page, an explanatory note, and Part C listing exhibits, and it does not modify any other part of the registration statement. The registration statement continues to permit offerings from time to time after the effective date.
Prospect Capital Corporation (PSEC) filed Post-Effective Amendment No. 115 which records corporate housekeeping details including entities it controls as of December 31, 2022, the locations where required accounts and records are kept, and routine securities-act undertakings. The filing names the adviser and transfer agent, lists custodians, and confirms obligations about prospectus delivery and post-effective amendments. The document is procedural and contains no financial results.
M. Grier Eliasek, Chief Operating Officer and Director of Prospect Capital Corp (PSEC), reported an open-market purchase of 370,000 shares of common stock on 09/25/2025 at a price of $2.71 per share. After the transaction the reporting person beneficially owned 2,501,130.422 shares. The Form 4 was signed on 09/29/2025.
John F. Barry III, a director, chief executive officer and reported 10% owner of Prospect Capital Corp (PSEC), purchased 925,000 shares of common stock on 09/25/2025 at $2.7219 per share. After the transaction he directly beneficially owned 86,067,158.198 shares; his spouse holds 372,363.396 shares indirectly. The Form 4 reports this non-derivative acquisition and identifies the reporting person’s role with the issuer.
Prospect Capital Corp (PSEC) insider purchase disclosed on Form 4. The reporting person, John F. Barry III, filed that on 09/24/2025 he acquired 741,158 shares of common stock at $2.617 per share. Following the transaction he beneficially owned 85,142,158.198 shares directly. The filing also reports 372,363.396 shares held indirectly by spouse. The form is signed 09/26/2025.